跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DYSPORT THERAPEUTIC - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
DYSPORT THERAPEUTIC
Authorized
STANDARD
DYSPORT THERAPEUTIC
ipsen biopharmaceuticals canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
dcae1e138b02699a
Company
ipsen biopharmaceuticals canada inc
Type
Standard
Approval Details
Approval Id
dcae1e138b02699a
Drug Approval Canada Name
DYSPORT THERAPEUTIC
Product Name
DYSPORT THERAPEUTIC
Status
Marketed
Status Date
2022-04-06
Original Market Date
2017-02-27
Din
02456117
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intramuscular
Schedule
Prescription , Schedule D
Ahfs
12:20.20.24
Atc Original
M03AX01 BOTULINUM TOXIN
Atc Name
m 03 ax 01
Aig Number
0153614002
Company Name
ipsen biopharmaceuticals canada inc
Company Address
SUITE 500, 5050 Satellite Drive, Mississauga, Ontario, Canada, L4W 0G1
Active Ingredients
ABOBOTULINUMTOXINA
500 UNIT / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
dcae1e138b02699a
Type
Standard
Back to Health Canada Approvals